| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/03/2008 | CN101254179A Gatifloxacin capsules and method of preparing the same |
| 09/03/2008 | CN101254178A Gliclazide controlled release tablets |
| 09/03/2008 | CN101254177A Dantrolene sodium chewable tablet and method of preparing the same |
| 09/03/2008 | CN101254176A Freeze-dried powder needle preparations taking dantrolene sodium as activity component and preparation technique thereof |
| 09/03/2008 | CN101254175A Boletic acid buddhist nun azoles phenyl ketone freeze-dried powder and method of preparing the same |
| 09/03/2008 | CN101254174A Freeze-dried injection containing carbazochrome sodium sulfonate and method of preparing the same |
| 09/03/2008 | CN101254173A Soluble semen iris lacteae powder preparations and method of preparing the same |
| 09/03/2008 | CN101254172A Guacetisal dry-mixing suspending agents and method of preparing the same |
| 09/03/2008 | CN101254171A Spray containing small molecule disturbance ribonucleic acid |
| 09/03/2008 | CN101254170A An anticancer sustained release injection carrying clorfarabine and its synergist |
| 09/03/2008 | CN101254169A Sustained-release agent containing tuberculosis-resistance medicament |
| 09/03/2008 | CN101254168A Composite high-energy nutrient fluid for dog, grimalkin and fox and method of preparing the same |
| 09/03/2008 | CN101254167A Tree plant oil women's medical sanitary tampon and method of preparing the same |
| 09/03/2008 | CN101254166A An anticancer sustained release injection carrying clorfarabine and its synergist |
| 09/03/2008 | CN101254165A Skin osmosis promoting absorbing agent of cryptotanshinone |
| 09/03/2008 | CN101254155A Skin preparations for external use |
| 09/03/2008 | CN100415894C Process for producing isomaltose and use thereof |
| 09/03/2008 | CN100415801C Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof |
| 09/03/2008 | CN100415756C Oxalic adefovir dipivoxil, and crystalline form and preparing method and use thereof |
| 09/03/2008 | CN100415743C Derivatives of pyrimido [6.1-a] isoquinolin-4-one |
| 09/03/2008 | CN100415731C Compound for treating B type hepatitis and medication composition thereof |
| 09/03/2008 | CN100415296C Compositions containing inclusion complexes |
| 09/03/2008 | CN100415295C Method for preparing capsaicin carrier |
| 09/03/2008 | CN100415284C Process for preparing Liuwei aucklandia root tablet |
| 09/03/2008 | CN100415283C Medicine for resisting inflammation, contracting uterus and eliminating tumor and its preparation process |
| 09/03/2008 | CN100415282C Paste for treating cancers |
| 09/03/2008 | CN100415269C Cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet and its preparation method |
| 09/03/2008 | CN100415263C Chinese medicine for gynecological inflammation |
| 09/03/2008 | CN100415259C Medicine for treating coronary heart disease and preparation thereof |
| 09/03/2008 | CN100415258C Chinese traditional medicine composition for treating leucopenia and preparation and quality controlling method thereof |
| 09/03/2008 | CN100415257C Application of peru apple in preparation of medicine |
| 09/03/2008 | CN100415255C Composition of Chinese traditional medicine, and preparation method thereof |
| 09/03/2008 | CN100415254C Anti-inflammatory and heat-relieving Chinese-herb preparation |
| 09/03/2008 | CN100415252C Chinese medicinal composition for strengthening body and enriching blood and its preparation method |
| 09/03/2008 | CN100415246C Compositions for preparing external carbon dioxide agents |
| 09/03/2008 | CN100415245C Post-surgery anti-accretion material capable of gelatinized in situ or by injection and preparation process thereof |
| 09/03/2008 | CN100415244C Nasal drip liquor for treating rhinitis and nasosinusitis |
| 09/03/2008 | CN100415242C Drop pills of vepeside and preparation process thereof |
| 09/03/2008 | CN100415241C Medicinal composition for treating cardio-cerebrovascular diseases |
| 09/03/2008 | CN100415239C Highly concentrated solution of finasteride and use thereof |
| 09/03/2008 | CN100415237C Aciclovir compositions containing dimethicone |
| 09/03/2008 | CN100415235C Medicinal composition containing an HMG-CoA reductase inhibitor |
| 09/03/2008 | CN100415234C Antifungal composition with enhanced bioavailability |
| 09/03/2008 | CN100415233C Oral formulations |
| 09/03/2008 | CN100415232C Medicine composition for treating viral hepatitis and its preparing method |
| 09/03/2008 | CN100415231C Osmotic pump type controlled release preparation of kurarinone and its preparing method |
| 09/03/2008 | CN100415230C Dispersion tablets of penicillin V potassium, and its preparing method |
| 09/03/2008 | CN100415229C Itraconazole soft capsule, and its preparation method |
| 09/03/2008 | CN100415228C Medicine containing galangin and preparation method thereof |
| 09/03/2008 | CN100415224C Compositions comprising fatty acids and amino acids |
| 09/03/2008 | CN100415223C Controlled releasing oral medicine composition |
| 09/03/2008 | CN100415221C Curcumin lyophilized liposome for injection and its preparing method |
| 09/03/2008 | CN100415216C Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 09/03/2008 | CN100415215C Wild camellia seed oil soft capsule |
| 09/03/2008 | CN100415214C Preparing method gynaecologic capsule for regulating menstruation |
| 09/03/2008 | CN100415213C Preparation method of medicinal single layer core osmotic pump tablet |
| 09/03/2008 | CN100415212C An oral preparation containing caderofloxacin lactate |
| 09/03/2008 | CN100415211C AIDS drug didanosine granula composition and its preparation method |
| 09/03/2008 | CN100415210C Peptide/lipid complex formation by co-lyophilization |
| 09/03/2008 | CN100415209C Cough stopping preparation and process for preparing the same |
| 09/03/2008 | CN100415205C Emulsions with a concentrated internal oil phase |
| 09/03/2008 | CN100415188C Condom with erectogenic composition |
| 09/02/2008 | US7420069 Crystalline composition containing escitalopram |
| 09/02/2008 | US7420068 Crystals of purified escitalopram oxalate with a broad particle size distribution suitable for use in direct compressionproduced by treating a solution of citalopram with a hydroxyl group scavenger and reacting with oxalic acid; refluxing, cooling, salt formation, seeding, filtration |
| 09/02/2008 | US7420024 Changes its shape and volume in response to change in pH and in response to change in temperature, formed by photocrosslinking of dextran-maleic acid monoester and N-isopropylacrylamide; drug delivery; decreased water retention with increased temperature and increased swelling ratio with increased pH |
| 09/02/2008 | US7420009 Thermoplastic resin (polyvinyl acetates having different molecular weight distributions) and hydroxyl-modified thermoplastic resin (phenol-modified coumarone-indene resin) dissolved in a mixture of acetone and ethanol |
| 09/02/2008 | US7419996 include a benzimidazole (mebendazole, fenbendazole, omeprazole), a polyol (polyethylene glycol), and a dipolar aprotic solvent (N,N-dimethylacetamide or dimethylsulfoxide); improved drug solubility, drug release from the formulation, and bioavailability |
| 09/02/2008 | US7419971 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application |
| 09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
| 09/02/2008 | US7419687 carriers for group IB compounds such as silver nitrate comprising beads made of inert polymers, ceramics or stainless steels, used for treatment of menorrhagia |
| 09/02/2008 | US7419686 For preventing oral abuse of an oral opioid formulation; provides a negative, "aversive" experience when a large amount of the opioid, e.g., about 2-3 times the usually prescribed dose, is taken by or administered to a physically dependent subject |
| 09/02/2008 | US7419685 Process for producing solid dosage forms |
| 09/02/2008 | US7419684 System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same |
| 09/02/2008 | US7419683 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 09/02/2008 | US7419677 Treatment device and method of using the same |
| 09/02/2008 | US7419504 Poly(ester amide) block copolymers |
| 09/02/2008 | US7419484 Administering device with an osmotic drive |
| 09/02/2008 | CA2461757C Nicotine formulations comprising chocolate and use thereof |
| 09/02/2008 | CA2461517C Nicotine formulations comprising cocoa and use thereof |
| 09/02/2008 | CA2426956C Pharmaceutical compositions comprising ascomycin derivatives |
| 09/02/2008 | CA2389333C Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 09/02/2008 | CA2384922C Topical glycopyrrolate product for the reduction of sweating |
| 09/02/2008 | CA2365239C Injection-molding process for (meth)acrylate copolymers with tertiary ammonium groups |
| 09/02/2008 | CA2351068C Drug delivery device, especially for the delivery of progestins and estrogens |
| 09/02/2008 | CA2316052C Sustained release formulations of water soluble peptides |
| 09/02/2008 | CA2306881C Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 09/02/2008 | CA2276269C N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
| 09/02/2008 | CA2243237C Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
| 08/28/2008 | WO2008103852A1 Transdermal delivery of dexamethasone and promethazine |
| 08/28/2008 | WO2008103594A1 Methods of use of biomaterial and injectable implant containing biomaterial |
| 08/28/2008 | WO2008103579A1 Lipid microemulsions |
| 08/28/2008 | WO2008103431A2 Dnai - liposomes |
| 08/28/2008 | WO2008103368A1 Amine polymer compositions |
| 08/28/2008 | WO2008103345A2 Hemostatic compositions and therapeutic regimens |
| 08/28/2008 | WO2008103046A1 A controlled release composition |
| 08/28/2008 | WO2008103045A1 A controlled release composition comprising a recombinant gelatin |
| 08/28/2008 | WO2008102880A1 Antimycotic patch |
| 08/28/2008 | WO2008102855A1 Composition for treatment of cartilage disease |
| 08/28/2008 | WO2008102379A1 Stable sustained release formulations of fluvastatin |
| 08/28/2008 | WO2008102349A2 Terbinafine formulation for iontophoresis |